|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/14 | (2006.01) |
| A61P 3/00 | (2018.01) | ||
| A61P 3/00 | (2006.01) | ||
| C07D 471/14 | (2013.01) | ||
| A61K 31/4375 | (2006.01) |
| (11) | Number of the document | 3500570 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17762266.9 |
| Date of filing the European patent application | 2017-08-18 | |
| (97) | Date of publication of the European application | 2019-06-26 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/047644 |
| Date | 2017-08-18 |
| (87) | Number | WO 2018/035477 |
| Date | 2018-02-22 |
| (30) | Number | Date | Country code |
| 201662377119 P | 2016-08-19 | US |
| (72) |
SEMPLE, Graeme , US
REN, Albert S. , US
SCHRADER, Thomas O. , US
KASEM, Michelle , US
ZHU, Xiuwen , US
|
| (73) |
Arena Pharmaceuticals, Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE |
| 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE |